Morningstar Investor users sign in here.

Company Profile

  • Business description

    BioInvent International AB is a clinical-stage biotech company. It discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The company's validated, proprietary F.I.R.S.T technology platform identifies both targets and the antibodies that bind to them, generating many new drug candidates to fuel the company's own clinical development pipeline and providing licensing and partnering opportunities. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin’s lymphoma, and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers.

  • Contact

    Ideongatan 1
    The Gamma Building
    Lund SE-223 70
    SWE

    T: +46 462868550

    E: svein.mathisen@bioinvent.com

    https://www.bioinvent.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    112

Stocks News & Analysis

stocks

How to assess a company’s debt load

BHP is used as an example to show how to assess the impact of too much debt on financial risk and flexibility.
stocks

Top ASX banking opportunities

Bank shares rally as bad debt concerns ease but look overvalued.
video

The impact on investors from Facebook's about face on news

Morningstar's Director of Equity Research Brian Han talks about why Facebook decided not to renew media deals and the impact for the companies and investors.

Markets

Index
Last price
Change
% Change
All Ordinaries 8,050.20 23.90 -0.30%
CAC 40 8,010.83 12.91 -0.16%
DAX 40 17,930.32 24.16 -0.13%
Dow JONES (US) 37,983.24 475.84 -1.24%
FTSE 100 7,995.58 71.78 0.91%
HKSE 16,721.69 373.34 -2.18%
NASDAQ 16,175.09 267.10 -1.62%
Nikkei 225 39,523.55 80.92 0.21%
NZX 50 Index 11,931.32 2.99 -0.03%
S&P 500 5,123.41 75.65 -1.46%
S&P/ASX 200 7,788.10 25.50 -0.33%
SSE Composite Index 3,019.47 14.77 -0.49%

Market Movers

Name
Last price
Change
% Change
The Star Entertainment Group Ltd SGR 0.51 0.04 -7.34%
Peninsula Energy Ltd PEN 0.11 0.01 -4.55%
Red 5 Ltd RED 0.43 0.03 6.17%
Sayona Mining Ltd SYA 0.04 0.00 0.00%
Judo Capital Holdings Ltd JDO 1.38 0.00 0.00%
Genex Power Ltd GNX 0.27 0.02 6.00%
Imugene Ltd IMU 0.09 0.00 -3.16%
Pantoro Ltd PNR 0.08 0.00 3.70%
Telstra Group Ltd TLS 3.76 0.04 -1.05%
Pilbara Minerals Ltd PLS 4.05 0.03 0.75%